
Kurt Schumacher
Medical Director, Transplant Program and Division Director · University of Michigan
Credentials: · · · ·
History
PresentTransplant Program and Division Director · University of Michigan
Present
Present
- 2008–2011

Research
Circulation · 2019 · 808 citations
NF-kappa B activation mediates doxorubicin-induced cell death in N-type neuroblastoma cells
Journal of Biological Chemistry · 2001 · 145 citations
Circulation · 2020 · 134 citations
- DP
23 papers
- AM
19 papers · 3 as a fellow

18 papers

17 papers
- HL
16 papers

15 papers

13 papers · 1 as a fellow

10 papers
Grants
- 2024–2030
Pediatric Heart Network University of Michigan
National Heart, Lung, and Blood Institute · UM1
PI · $1.3M · University of Michigan at Ann Arbor
- 2016–2023
IND119678 Phase II Safety & Efficacy of Inhaled Activase for Acute Plastic Bronchitis 12-10-14
Food and Drug Administration · R01
PI · $1.7M · University of Michigan at Ann Arbor
Clinical trials
- 2019–2026
Principal investigator · Terminated
University of Michigan
- 2018–2020
Principal investigator · Completed · Phase 3
Mezzion Pharma Co. Ltd
- 2026–2029
Site PI · Recruiting
Carelon Research
- 2023–2025
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
Site PI · Recruiting · Phase 3
Mezzion Pharma Co. Ltd



